跳至主要内容
临床试验/DRKS00011624
DRKS00011624已完成不适用

Risk factors for mortality and cardiovascular diseases in older adults in a primaray care setting – longitudinal analysis of the getABI-study

Ruhr-Universität Bochum0 个研究点目标入组 6,880 人开始时间: 2017年6月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6,880

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
65 Years 至 one(—)
性别
All

入选标准

  • life expectancy more than six months

排除标准

  • missing legal competence

研究者

相似试验

已完成
不适用
Mortality and risk factors for cardiovascular and non-cardiovascular disease in Japanese with impaired glucose metabolism
JPRN-UMIN000036648Hiroshima Atomic Bomb Casualty Council19,248
进行中(未招募)
1 期
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849
EUCTR2012-003946-34-CZVIVUS, Inc.16,000
进行中(未招募)
1 期
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 14.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849
EUCTR2012-003946-34-SKVIVUS, Inc.16,000
进行中(未招募)
不适用
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.0Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849
EUCTR2012-003946-34-GBVIVUS, Inc.16,000
尚未招募
不适用
cardiovascular complications in oncosurgeries- incidence and risk factors
CTRI/2021/06/034184Regional Cancer Centre